You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Concurrent Chemotherapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nasopharyngeal Carcinoma Trial in Fuzhou (without concurrent cisplatin chemo, with concurrent cisplatin chemo)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • without concurrent cisplatin chemotherapy
  • with concurrent cisplatin chemotherapy
  • Fuzhou, Fujian, China
    Department of radiation oncology, Fujian cancer hospital
Oct 18, 2023

Incorporating Biometric Data for Patients Receiving Concurrent

Not yet recruiting
  • Cancer
    • Wilmington, North Carolina
      Novant Health Cancer Institute Radiation Oncology
    Jul 7, 2023

    Nasopharyngeal Carcinoma Trial in Guangzhou, Zhongshan, Nanning (IMRT and concurrent cisplatin, gemcitabine and cisplatin

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • IMRT and concurrent cisplatin
    • gemcitabine and cisplatin (Induction chemotherapy)
    • Guangzhou, Guangdong, China
    • +3 more
    Jul 30, 2023

    Nasopharyngeal Carcinoma Trial in Guangzhou (Induction chemo plus Concurrent chemo, Concurrent chemo, IMRT)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • Induction chemotherapy plus Concurrent chemotherapy
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 17, 2022

    Lymphoma Trial in Houston (Radiation Therapy, Dexamethasone, Etoposide phosphate)

    Recruiting
    • Lymphoma
    • Radiation Therapy
    • +5 more
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Dec 9, 2022

    Nasopharyngeal Carcinoma, De-escalation Therapy Trial in Guangzhou (Cisplatin-based induction chemo, Full course of PD-1/PD-L1

    Recruiting
    • Nasopharyngeal Carcinoma
    • De-escalation Therapy
    • Cisplatin-based induction chemotherapy
    • +4 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 16, 2023

    Lung Cancer, Esophageal Cancer Trial in Philadelphia (Pulsed Low Dose Radiation, Carboplatin, Paclitaxel)

    Recruiting
    • Lung Cancer
    • Esophageal Cancer
    • Pulsed Low Dose Radiation
    • +2 more
    • Philadelphia, Pennsylvania
      Fox Chase Cancer Center
    Dec 2, 2022

    Muscle Invasive Bladder Urothelial Carcinoma Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

    Not yet recruiting
    • Muscle Invasive Bladder Urothelial Carcinoma
    • Daily Adaptive External Beam Radiation Therapy
    • Saint Louis, Missouri
      Washington University, St. Louis
    Jan 17, 2023

    Bladder Cancer Trial in Seoul (hypo-IMRT)

    Recruiting
    • Bladder Cancer
    • hypo-IMRT
    • Seoul, Korea, Republic of
      Samsung Medical Center
    Jul 6, 2022

    Nasopharyngeal Carcinoma, Immune Checkpoint Inhibitor, Radiotherapy Trial (radiation, drug, biological)

    Not yet recruiting
    • Nasopharyngeal Carcinoma
    • +3 more
    • Intensity Modulated Radiation Therapy
    • +3 more
    • (no location specified)
    Jul 11, 2023

    NSCLC Metastatic Trial in Chengdu (Camrelizumab, stereotactic body radiation therapy, Chemotherapy)

    Recruiting
    • Non-small Cell Lung Cancer Metastatic
    • Chengdu, Sichuan, China
      Sichuan Cancer Hospital & Institute
    Jul 21, 2022

    NSCLC Trial in Philadelphia (Pembrolizumab)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Nov 1, 2022

    Local Advanced High Risk Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT combine with cisplatin concurrent chemo, IMRT combine

    Recruiting
    • Local Advanced High Risk Nasopharyngeal Carcinoma
    • IMRT combine with cisplatin concurrent chemotherapy
    • IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Apr 9, 2022

    Local Advanced High Risk Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT combine with cisplatin concurrent chemo, IMRT combine

    Active, not recruiting
    • Local Advanced High Risk Nasopharyngeal Carcinoma
    • IMRT combine with cisplatin concurrent chemotherapy
    • IMRT combine with cisplatin concurrent chemotherapy plus capecitabine adjuvant chemotherapy
    • Guangzhou, Guangdong, China
      Cancer Center, Sun Yat-sen University
    Mar 13, 2022

    Esophageal Squamous Cell Carcinoma Trial in Guangzhou (Split-course hypo-CCRT, Induction chemo-immunotherapy, Concurrent chemo)

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • Split-course hypo-CCRT
    • +2 more
    • Guangzhou, Guangdong, China
      Sun yat-sen University Cancer Center
    Aug 26, 2023

    Limited Stage Small Cell Lung Cancer Trial (HLX10, hypofractionated radiotherapy, Prophylactic Cranial Irradiation (PCI))

    Not yet recruiting
    • Limited Stage Small Cell Lung Cancer
    • (no location specified)
    Jun 29, 2022

    Anal Canal Cancer Stage III, Anal Squamous Cell Carcinoma, Anal Canal Cancer Trial in Guangzhou (PD-1 inhibitor, concurrent

    Recruiting
    • Anal Canal Cancer Stage III
    • +3 more
    • PD-1 inhibitor
    • concurrent chemoradiotherapy
    • Guangzhou, Guangdong, China
      The Sixth Affiliated Hospital of Sun Yat-sen University
    May 10, 2022

    Esophageal Squamous Cell Carcinoma, Chemo Effect, Side Effect of Drug Trial in Nanjing (Consolidation chemo (4 courses),

    Recruiting
    • Esophageal Squamous Cell Carcinoma
    • +2 more
    • Consolidation chemotherapy (4 courses)
    • Concurrent chemotherapy (2 courses)
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital of Nanjing Medical University
    Mar 16, 2023

    Esophageal Squamous Cell Carcinoma Trial in Nanjing (Carrelizumab, Paclitaxel injection, Cisplatin)

    Enrolling by invitation
    • Esophageal Squamous Cell Carcinoma
    • Nanjing, China
      The First Affiliated Hospital of Nanjing Medical University
    Sep 19, 2023

    NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

    Recruiting
    • Non-small Cell Lung Cancer
    • Hypofractionated radiotherapy
    • +4 more
    • Guangzhou, Guangdong, China
      Sun yat-sen university cancer center
    Nov 14, 2023

    Cervical Cancer, Stage IIB Trial in Mexico City (Placebo dairy beverage)

    Completed
    • Cervical Cancer, Stage IIB
    • Placebo dairy beverage
    • Mexico City, Tlalpan, Mexico
      National Cancer Institute of Mexico
    Feb 16, 2023

    Nasopharyngeal Carcinoma Trial in Shanghai (cetuximab (CTX) or nimotuzumab (NTZ))

    Completed
    • Nasopharyngeal Carcinoma
    • cetuximab (CTX) or nimotuzumab (NTZ)
    • Shanghai, China
      Xiaoshen Wang
    Mar 23, 2022

    Nasopharyngeal Carcinoma Trial in Guangzhou (IMRT, induction chemo, cisplatin concurrent chemo)

    Recruiting
    • Nasopharyngeal Carcinoma
    • IMRT
    • +2 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen Universitty Cancer Center
    May 5, 2022

    Nasopharyngeal Carcinoma Trial in Shanghai (Camrelizumab, Nimotuzumab, neoadjuvant chemo and CCRT)

    Recruiting
    • Nasopharyngeal Carcinoma
    • Shanghai, Shanghai, China
      Fudan Universtiy Shanghai Cancer Centre
    Mar 6, 2023

    Uterine Cervical Tumors, Chemoradiotherapy, Adjuvant Chemo Trial in Liuzhou (paclitaxel combined with platinum)

    Recruiting
    • Uterine Cervical Neoplasms
    • +2 more
    • paclitaxel combined with platinum
    • Liuzhou, Guangxi, China
      the Fourth Affiliated Hospital of Guangxi Medical University
    Feb 16, 2023